Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Psychotherapy × 1 year × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

Cisplatin 28 pembrolizumab 22 Magnetic Resonance Spectroscopy 22 Carboplatin 21 Paclitaxel 17 Gemcitabine 17 Specimen Handling 16 Oxaliplatin 15 Drug Therapy 15 atezolizumab 14 Nivolumab 14 Doxorubicin 14 Cyclophosphamide 14 Capecitabine 14 Bevacizumab 14 Dexamethasone 13 Radiotherapy 12 Pemetrexed 11 Docetaxel 11 Vincristine 10 Radiation 10 Prednisone 10 Cytarabine 10 venetoclax 9 Trastuzumab 9 Ipilimumab 9 Fluorouracil 9 Rituximab 8 Platinum 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05398484 2025-12-04

Psilocybin Therapy in Advanced Cancer

NYU Langone Health

Phase 2/3 Recruiting

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡